Floatz logo

Fludarabine

Non-Hodgkin Lymphoma

Memorial Sloan Kettering Cancer CenterSmall moleculePhase 4 / ApprovedActive
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
71/ 100
Competitive Position
73/ 100

Competitive context

64 Active assets in the Non-Hodgkin Lymphoma cohort.

Asset / SponsorPhaseRating
PREDNISONE TABLETS
National Cancer Institute (NCI)
Phase 3BBB
Monomethyl Fumarate
Memorial Sloan Kettering Cancer Center
Phase 3BB
Eloxatin
National Cancer Institute (NCI)
Phase 4BB
Mosunetuzumab
Bristol-Myers Squibb
Phase 3BB
CYCLOSPORIN A
City of Hope Medical Center
Phase 3BB

View all 50 →

Same molecule, other indications

Fludarabine is also rated in:

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →
Fanconi anemiaDormant
BBB
Indicative ·
76 / 100
View asset →
Recurrent Adult Diffuse Large Cell LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →